{"symbol": "SURF", "companyName": "Surface Oncology Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "https://www.surfaceoncology.com", "description": "Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.", "CEO": "J. Jeffrey Goater", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}